Drug Database
L01EB02 erlotinib
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Erlotinib 100 mg film-coated tablets
- POM Erlotinib 150 mg film-coated tablets
- POM Erlotinib 25 mg film-coated tablets
- POM Erlotinib Amarox 100 mg film-coated tablets
- POM Erlotinib Amarox 150 mg film-coated tablets
- POM Erlotinib Amarox 25 mg film-coated tablets
- POM Erlotinib Glenmark 100 mg film-coated tablets
- POM Erlotinib Glenmark 150 mg film-coated tablets
- POM Erlotinib Glenmark 25 mg film-coated tablets
- POM Erlotinib Sandoz 100 mg film-coated tablets
- POM Erlotinib Sandoz 150 mg film-coated tablets
- POM Erlotinib Sandoz 25 mg film-coated tablets
- POM Erlotinib Tillomed 25 mg, 100mg and 150mg film-coated tablets
- POM Erlotinib Zentiva 150 mg film-coated tablets
- POM Erlotinib Zentiva 25 mg film-coated tablets
- POM Tarceva 25 mg, 100 mg & 150 mg Film-coated Tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).